These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31011396)

  • 81. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unsuspected exposure to beryllium: potential implications for sarcoidosis diagnoses.
    Laczniak AN; Gross NA; Fuortes LJ; Field RW
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):163-9. PubMed ID: 25078645
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A reconsideration of acute Beryllium disease.
    Cummings KJ; Stefaniak AB; Virji MA; Kreiss K
    Environ Health Perspect; 2009 Aug; 117(8):1250-6. PubMed ID: 19672405
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Toxic beryllium: new solutions for a chronic problem.
    Fields S
    Environ Health Perspect; 2001 Feb; 109(2):A74-9. PubMed ID: 11266347
    [No Abstract]   [Full Text] [Related]  

  • 85. Beryllium's public relations problem: protecting workers when there is no safe exposure level.
    Michaels D; Monforton C
    Public Health Rep; 2008; 123(1):79-88. PubMed ID: 18348484
    [No Abstract]   [Full Text] [Related]  

  • 86. Biological exposure metrics of beryllium-exposed dental technicians.
    Stark M; Lerman Y; Kapel A; Pardo A; Schwarz Y; Newman L; Maier L; Fireman E
    Arch Environ Occup Health; 2014; 69(2):89-99. PubMed ID: 24205960
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Use of the Beryllium Lymphocyte Proliferation Test (BeLPT) for screening.
    Lebeau J
    J Occup Environ Med; 2007 Apr; 49(4):357-8; author reply 358-9. PubMed ID: 17426515
    [No Abstract]   [Full Text] [Related]  

  • 89. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Chronic beryllium disease: a hypersensitivity disorder.
    Rossman MD
    Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Occupational interstitial lung disease].
    De Vuyst P
    Rev Mal Respir; 2006 Apr; 23 Suppl 2():4S76-4S77. PubMed ID: 16733403
    [No Abstract]   [Full Text] [Related]  

  • 92. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment.
    Borak J; Woolf SH; Fields CA
    J Occup Environ Med; 2006 Sep; 48(9):937-47. PubMed ID: 16966961
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort.
    Schuler CR; Kitt MM; Henneberger PK; Deubner DC; Kreiss K
    J Occup Environ Med; 2008 Dec; 50(12):1343-50. PubMed ID: 19092488
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A 65-year-old factory worker with dyspnea on exertion and a normal chest x-ray.
    Saber W; Dweik RA
    Cleve Clin J Med; 2000 Nov; 67(11):791-2, 794, 797-8, 800. PubMed ID: 11104328
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Beryllium: a paradigm for occupational lung disease and its prevention.
    Kreiss K
    Occup Environ Med; 2011 Nov; 68(11):787-8. PubMed ID: 21984591
    [No Abstract]   [Full Text] [Related]  

  • 97. Immune mechanisms in beryllium lung disease.
    Deodhar SD; Barna BP
    Cleve Clin J Med; 1991; 58(2):157-60. PubMed ID: 2025920
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.
    Williams WJ; Williams WR
    Thorax; 1983 Jan; 38(1):41-4. PubMed ID: 6845261
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
    Price CD; Williams WJ; Pugh A; Joynson DH
    J Clin Pathol; 1977 Jan; 30(1):24-28. PubMed ID: 320228
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.